Loutfy Benkerrour

Title: Loutfy Benkerrour: Innovator in Pediatric Formulations

Introduction

Loutfy Benkerrour is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in developing formulations that cater to pediatric needs. His innovative approach has led to advancements in the way medications are administered to children.

Latest Patents

Loutfy Benkerrour holds a patent for a pediatric formulation of gatifloxacin. This invention provides a quinolone antibacterial agent that is adequately taste-masked for use in pediatric formulations. The patent describes a crystalline co-precipitate of gatifloxacin combined with stearic acid and palmitic acid in a specific weight ratio. This formulation effectively masks the bitter taste of gatifloxacin, making it more palatable for children. The taste-masking is effective throughout a full dosage cycle, typically lasting fourteen days. Additionally, the gatifloxacin in these crystalline co-precipitates is readily available for absorption from the stomach, enhancing its efficacy.

Career Highlights

Loutfy Benkerrour is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on developing innovative solutions that improve patient outcomes, particularly for younger populations. His dedication to pediatric formulations showcases his commitment to addressing the unique challenges faced in this area of medicine.

Collaborations

Loutfy has collaborated with esteemed colleagues, including Luigi Esposito and Sunanda A Ranadive. Their combined expertise contributes to the advancement of pharmaceutical innovations and the development of effective treatments.

Conclusion

Loutfy Benkerrour's contributions to pediatric formulations exemplify the importance of innovation in medicine. His work not only improves the administration of essential medications to children but also highlights the ongoing need for advancements in pharmaceutical science.